A comparison between the continual reassessment method and D-optimum design for dose finding in phase I clinical trials

Pubblicato online: 10 dic 2016

Pagine: 69 - 82

DOI: https://doi.org/10.1515/bile-2016-0006

Parole chiave

Dose finding studies, Phase I trial, Maximum tolerated dose, Continual reassessment method, -optimum design

© 2016 M. Iftakhar Alam, published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.